NCT02068794: A trial that was reported late by Mayo Clinic
This trial has reported, although it was 61 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02068794 |
|---|---|
| Title | Phase I/II Trial of Intraperitoneal Administration of Adipose Tissue Derived Mesenchymal Stem Cells Infected With a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 25, 2014 |
| Completion date | March 15, 2024 |
| Required reporting date | March 15, 2025, midnight |
| Actual reporting date | May 15, 2025 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | 61 |